• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Kremen2 表达增加预示着结肠癌预后不良。

Increased Kremen2 predicts worse prognosis in colon cancer.

机构信息

Division of Colorectal and Anal Surgery, Department of Gastrointestinal Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.

Department of Breast and Thyroid Surgery, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

出版信息

Pathol Oncol Res. 2023 Apr 12;29:1611082. doi: 10.3389/pore.2023.1611082. eCollection 2023.

DOI:10.3389/pore.2023.1611082
PMID:37123533
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10130194/
Abstract

Colon cancer (CC) is the fifth most prevalent cancer around the globe and poses a major risk to human health. Even though Kremen2 serves as a prognostic indicator in individuals with malignant tumours, its role in evaluating the prognosis of individuals with colon cancer has not been confirmed. Here, we examined the protein expression of Kremen2 in CC tissues and paired adjacent normal tissues by immunohistochemistry (IHC), then analyzed the clinical and RNA-seq data presented in The Cancer Genome Atlas (TCGA) database to confirm the relationship between Kremen2 levels and CC. In addition, the associations between Kremen2 mRNA expression and infiltrating immune cells were examined. The study showed that the mRNA expression and protein level of Kremen2 were increased in CC tissues compared with adjacent normal tissues. According to Kaplan-Meier analysis, high Kremen2 expression in CC was linked to poor overall survival and progression-free survival. Clinical correlation analysis highlighted that a high level of Kremen2 expression was strongly linked with tumour progression, particularly lymph node metastasis. Cox regression analysis highlighted that Kremen2 was an independent prognostic indicator for CC. Bioinformatic studies highlighted that Kremen2 might be associated with the immune status in CC. Increased Kremen2 could serve as a potential prognostic CC biomarker.

摘要

结肠癌(CC)是全球第五大常见癌症,对人类健康构成重大威胁。尽管 Kremen2 是恶性肿瘤患者的预后指标,但它在评估结肠癌患者预后中的作用尚未得到证实。在这里,我们通过免疫组织化学(IHC)检测 CC 组织和配对的相邻正常组织中的 Kremen2 蛋白表达,然后分析美国癌症基因组图谱(TCGA)数据库中提供的临床和 RNA-seq 数据,以确认 Kremen2 水平与 CC 之间的关系。此外,还检查了 Kremen2 mRNA 表达与浸润免疫细胞之间的关联。研究表明,与相邻正常组织相比,CC 组织中 Kremen2 的 mRNA 表达和蛋白水平增加。根据 Kaplan-Meier 分析,CC 中高 Kremen2 表达与总生存期和无进展生存期不良相关。临床相关性分析强调,高水平的 Kremen2 表达与肿瘤进展,特别是淋巴结转移密切相关。Cox 回归分析强调 Kremen2 是 CC 的独立预后指标。生物信息学研究强调,Kremen2 可能与 CC 中的免疫状态有关。增加的 Kremen2 可能成为 CC 的潜在预后生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/10130194/b1b1fe91ab5a/pore-29-1611082-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/10130194/073090987f5b/pore-29-1611082-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/10130194/32e550413143/pore-29-1611082-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/10130194/825e4c20d8e0/pore-29-1611082-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/10130194/b6706c49e105/pore-29-1611082-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/10130194/c3a702f43d32/pore-29-1611082-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/10130194/da8bdf7b656a/pore-29-1611082-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/10130194/b1b1fe91ab5a/pore-29-1611082-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/10130194/073090987f5b/pore-29-1611082-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/10130194/32e550413143/pore-29-1611082-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/10130194/825e4c20d8e0/pore-29-1611082-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/10130194/b6706c49e105/pore-29-1611082-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/10130194/c3a702f43d32/pore-29-1611082-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/10130194/da8bdf7b656a/pore-29-1611082-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/10130194/b1b1fe91ab5a/pore-29-1611082-g007.jpg

相似文献

1
Increased Kremen2 predicts worse prognosis in colon cancer.Kremen2 表达增加预示着结肠癌预后不良。
Pathol Oncol Res. 2023 Apr 12;29:1611082. doi: 10.3389/pore.2023.1611082. eCollection 2023.
2
Comprehensive Analysis of as an Immunotherapeutic and Prognostic Biomarker in Pan-Cancer.全面分析 作为泛癌种的免疫治疗和预后生物标志物
Anticancer Res. 2023 Oct;43(10):4491-4509. doi: 10.21873/anticanres.16643.
3
High expression of PLAC1 in colon cancer as a predictor of poor prognosis: A study based on TCGA data.PLAC1 在结肠癌中的高表达作为预后不良的预测指标:基于 TCGA 数据的研究。
Gene. 2020 Dec 30;763:145072. doi: 10.1016/j.gene.2020.145072. Epub 2020 Aug 19.
4
Correlation of INHBA Overexpression with Pathological Features, Antitumor Immune Response and Clinical Prognosis in Cervical Cancer.INHBA 过表达与宫颈癌病理特征、抗肿瘤免疫反应及临床预后的相关性。
Medicina (Kaunas). 2023 Mar 2;59(3):495. doi: 10.3390/medicina59030495.
5
Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.结肠癌的基因表达分类为分子亚型:特征描述、验证和预后价值。
PLoS Med. 2013;10(5):e1001453. doi: 10.1371/journal.pmed.1001453. Epub 2013 May 21.
6
DNM1: A Prognostic Biomarker Associated with Immune Infiltration in Colon Cancer-A Study Based on TCGA Database.DNM1:与结肠癌免疫浸润相关的预后生物标志物——基于 TCGA 数据库的研究。
Biomed Res Int. 2021 Nov 30;2021:4896106. doi: 10.1155/2021/4896106. eCollection 2021.
7
Lymph node CXCL17 messenger RNA: A new prognostic biomarker for colon cancer.淋巴结CXCL17信使核糖核酸:一种用于结肠癌的新预后生物标志物。
Tumour Biol. 2018 Sep;40(9):1010428318799251. doi: 10.1177/1010428318799251.
8
Retinoblastoma binding protein 4 up-regulation is correlated with hepatic metastasis and poor prognosis in colon cancer patients.视网膜母细胞瘤结合蛋白 4 的上调与结肠癌患者肝转移和预后不良相关。
Hepatobiliary Pancreat Dis Int. 2019 Oct;18(5):446-451. doi: 10.1016/j.hbpd.2019.08.006. Epub 2019 Aug 24.
9
Impact of gene reactivation by DNA demethylation on prognosis of patients with metastatic colon cancer.DNA 去甲基化对转移性结直肠癌患者预后的影响。
World J Gastroenterol. 2020 Jan 14;26(2):184-198. doi: 10.3748/wjg.v26.i2.184.
10
Evaluating macrophage migration inhibitory factor 1 expression as a prognostic biomarker in colon cancer.评估巨噬细胞移动抑制因子1表达作为结肠癌的预后生物标志物
Tumour Biol. 2020 Jun;42(6):1010428320924524. doi: 10.1177/1010428320924524.

引用本文的文献

1
Genetic Variants in the Gene Are Associated with Ramon Syndrome and Hereditary Gingival Fibromatosis.基因中的遗传变异与 Ramon 综合征和遗传性牙龈纤维瘤病有关。
Int J Mol Sci. 2024 Aug 15;25(16):8867. doi: 10.3390/ijms25168867.

本文引用的文献

1
Identification and validation of xenobiotic metabolism-associated prognostic signature based on five genes to evaluate immune microenvironment in colon cancer.基于五个基因的外源性物质代谢相关预后特征的鉴定与验证,以评估结肠癌中的免疫微环境。
J Gastrointest Oncol. 2021 Dec;12(6):2788-2802. doi: 10.21037/jgo-21-655.
2
CRYAB predicts clinical prognosis and is associated with immunocyte infiltration in colorectal cancer.CRYAB可预测结直肠癌的临床预后并与免疫细胞浸润相关。
PeerJ. 2021 Dec 10;9:e12578. doi: 10.7717/peerj.12578. eCollection 2021.
3
Structural Biology of the Tumor Microenvironment.
肿瘤微环境的结构生物学。
Adv Exp Med Biol. 2021;1350:91-100. doi: 10.1007/978-3-030-83282-7_4.
4
Identification of diagnostic signatures in ulcerative colitis patients via bioinformatic analysis integrated with machine learning.通过生物信息学分析与机器学习相结合的方法鉴定溃疡性结肠炎患者的诊断特征。
Hum Cell. 2022 Jan;35(1):179-188. doi: 10.1007/s13577-021-00641-w. Epub 2021 Nov 3.
5
Colon cancer cells secreted CXCL11 via RBP-Jκ to facilitated tumour-associated macrophage-induced cancer metastasis.结直肠癌细胞通过 RBP-Jκ 分泌 CXCL11 促进肿瘤相关巨噬细胞诱导的癌症转移。
J Cell Mol Med. 2021 Nov;25(22):10575-10590. doi: 10.1111/jcmm.16989. Epub 2021 Oct 16.
6
The impact of lymph node ratio on overall survival in patients with colorectal cancer.淋巴结比率对结直肠癌患者总生存的影响。
J Cancer Res Ther. 2021 Jul-Sep;17(4):1069-1074. doi: 10.4103/jcrt.JCRT_11_19.
7
Elevated tumor expression of Astroprincin (FAM171A1) is an independent marker of poor prognosis in colon cancer.肿瘤中 Astroprincin(FAM171A1)的高表达是结肠癌不良预后的独立标志物。
BMC Gastroenterol. 2021 Sep 4;21(1):341. doi: 10.1186/s12876-021-01918-y.
8
TRPV4 is a Prognostic Biomarker that Correlates with the Immunosuppressive Microenvironment and Chemoresistance of Anti-Cancer Drugs.瞬时受体电位香草酸亚型4(TRPV4)是一种预后生物标志物,与免疫抑制微环境和抗癌药物的化疗耐药性相关。
Front Mol Biosci. 2021 Jun 28;8:690500. doi: 10.3389/fmolb.2021.690500. eCollection 2021.
9
Low level of stromal lectin-like oxidized LDL receptor 1 and CD8 cytotoxic T-lymphocytes indicate poor prognosis of colorectal cancer.基质凝集素样氧化型 LDL 受体 1 和 CD8 细胞毒性 T 淋巴细胞水平低提示结直肠癌预后不良。
Cancer Rep (Hoboken). 2021 Aug;4(4):e1364. doi: 10.1002/cnr2.1364. Epub 2021 Mar 6.
10
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.